Scinovex
article Open AccessTop 1% cited

The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe

Hepatology · 2016 · Vol. 64(5) · pp. 1577–1586
Zobair M. YounossiDeirdre B BlissettRobert BlissettLinda HenryMaria StepanovaYoussef YounossiAndrei RacilaSharon HuntRachel Beckerman

Abstract

The analysis quantifies the enormity of the clinical and economic burdens of NAFLD, which will likely increase as the incidence of NAFLD continues to rise. (Hepatology 2016;64:1577-1586).

Liver Disease Diagnosis and TreatmentLiver Disease and TransplantationLiver Diseases and ImmunityNonalcoholic fatty liver diseaseMedicineLiver transplantationCirrhosisNonalcoholic steatohepatitisLiver diseaseDisease burdenChronic liver diseaseInternal medicineEnvironmental health

MeSH terms

AdolescentAdultAgedChildEuropeFemaleHumansMaleMarkov ChainsMiddle AgedUnited StatesModels, StatisticalIncidencePrevalenceCost of Illness

Funding

  • Gilead Sciences
Citations
1,268
FWCI
71.27
field-weighted impact
References
45
Percentile
100%
vs. same field & year
Citations per year
Cited by
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.